Bleeding with concomitant ibrutinib and oral anticoagulant therapy: A population-based cohort study

Am J Hematol. 2023 Mar;98(3):E49-E52. doi: 10.1002/ajh.26802. Epub 2022 Dec 7.

Neil Dhopeshwarkar^{1

2}, Wei Yang^{1

2}, Sean Hennessy^{1

2}, Joanna M Rhodes³, Adam Cuker^{4

5}, Charles E Leonard^{1

2}

¹ Center for Real-world Effectiveness and Safety of Therapeutics and the Center for Clinical Epidemiology and Biostatistics, Perelman School of Medicine, University of Pennsylvania, Philadelphia, Pennsylvania, USA.
² Department of Biostatistics, Epidemiology, and Informatics, Perelman School of Medicine, University of Pennsylvania, Philadelphia, Pennsylvania, USA.
³ Division of Hematology/Medical Oncology, Department of Medicine, Northwell Health, New Hyde Park, New York, USA.
⁴ Department of Medicine, Perelman School of Medicine, University of Pennsylvania, Philadelphia, Pennsylvania, USA.
⁵ Department of Pathology and Laboratory Medicine, Perelman School of Medicine, University of Pennsylvania, Philadelphia, Pennsylvania, USA.

No abstract available

Publication types